文献速递银屑病与炎症性皮肤病毛发、甲与色素性疾病

儿童异基因造血干细胞移植后非恶性晚期皮肤改变

Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children.
PubMed 文献 · J Am Acad Dermatol · 2018-03-26

单中心横断面队列研究纳入85例儿童异基因造血干细胞移植受者并做全身体检,中位随访年龄13.8岁、移植后3.6年;白癜风占14%、银屑病/脂溢性银屑病样占16%、脱发占25%、甲改变占6%,慢性移植物抗宿主病(cGVHD)与多种改变显著相关。

要点

  • 85例儿童移植受者中,白癜风14%(n=12)、银屑病/脂溢性银屑病样16%(n=14)、脱发25%(n=21)、甲改变6%(n=5)。
  • 白癜风与cGVHD史、原发免疫缺陷移植指征及移植年龄<10岁显著相关。
  • 脱发与cGVHD、白消安预处理及早期男性型脱发家族史显著相关;甲改变者全部有cGVHD。

核心结论

  • 儿童异基因造血干细胞移植受者尤其合并cGVHD者存在发生非恶性晚期皮肤改变的风险。

研究设计与样本

  • 单中心横断面队列研究,纳入85例儿童异基因造血干细胞移植受者,全部接受完整皮肤检查。

主要发现

  • 中位就诊年龄13.8岁,移植后中位时间3.6年。
  • 85例中白癜风14%(n=12)、银屑病/脂溢性银屑病样16%(n=14)、脱发25%(n=21)、甲改变6%(n=5)。
  • 白癜风显著相关因素包括cGVHD史、移植指征为原发免疫缺陷及移植年龄<10岁。
  • 脱发患者中52%呈雄激素性脱发模式;脱发显著相关因素包括cGVHD、白消安预处理及早期男性型脱发家族史。
  • 所有甲改变患者均有cGVHD。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 横断面设计无法确定皮肤改变的发生时间。
  • 未进行组织病理学对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited pediatric data on nonmalignant cutaneous changes, including autoimmune conditions and permanent alopecia, after hematopoietic stem cell transplantation (HSCT). OBJECTIVE: We sought to characterize late cutaneous changes and associated risk factors after allogeneic HSCT in children. METHODS: A cross-sectional cohort study of pediatric HSCT recipients was performed at a single institution. All participants underwent a full skin examination. RESULTS: The median visit age was 13.8 years, with a median time post-HSCT of 3.6 years. Of 85 patients, 14% (n = 12) had vitiligo, 16% (n = 14) had psoriasis/sebopsoriasis, 25% (n = 21) had alopecia, and 6% (n = 5) had nail changes. Factors significantly associated with vitiligo included a history of chronic graft-versus-host disease (cGVHD), transplant indication of primary immunodeficiency, and younger age at transplant (<10 years of age). Fifty-two percent of patients with alopecia had androgenetic alopecia patterns. Factors significantly associated with alopecia included cGVHD, busulfan conditioning, and family history of early male pattern alopecia. All patients with nail changes had cGVHD. LIMITATIONS: The cross-sectional design did not allow time of onset identification. Histopathologic correlation was not performed. CONCLUSION: Pediatric HSCT recipients, particularly those with cGVHD, are at risk for developing nonmalignant late cutaneous changes.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Huang JT, Song JS, Hawryluk EB, et al. Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children. J Am Acad Dermatol. 2018. PMID: 29588248. doi:10.1016/j.jaad.2018.03.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。